IONIS PHARMACEUTICALS INC (IONS) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000874015 · SEC filings checked Oct 16, 2026
Next report
Oct 28, 2026
Estimated from reporting history (91-day cycle, SEC 8-K item 2.02 results filings). Not confirmed.
Last close
$42.94
Polygon.io daily close, Oct 16, 2026. End of day, not live.
Trailing diluted EPS
$-3.46
Sum of quarters ending Jun 30, 2026, Mar 31, 2026, Dec 31, 2025, Sep 30, 2025
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $267.9M | $-114.6M | $-0.69 | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $246.1M | $-92.5M | $-0.56 | Filing |
| Dec 31, 2025 | Jan 12, 2026 | $203.3M | $-229.4M | $-1.41 | Filing |
| Sep 30, 2025 | Oct 29, 2025 | $156.7M | $-128.6M | $-0.80 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $452.0M | $123.6M | $0.70 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $131.6M | $-146.9M | $-0.93 | Filing |
| Dec 31, 2024 | Feb 19, 2025 | $226.6M | $-104.3M | $-0.66 | Filing |
| Sep 30, 2024 | Nov 6, 2024 | $133.8M | $-140.5M | $-0.95 | Filing |
What would IONIS PHARMACEUTICALS INC have to report for its valuation to change?
Trailing earnings are negative, so a price-to-earnings reverse model does not apply. The model is not shown rather than filled with assumptions.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.